2019
DOI: 10.1016/j.jtho.2019.08.1144
|View full text |Cite
|
Sign up to set email alerts
|

P1.13-07 Comparison of the 7th and 8th Edition of TNM Staging for NSCLC in Patients Undergoing Pulmonary Resection After Neoadjuvant/Induction Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

2
2
0

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(4 citation statements)
references
References 0 publications
2
2
0
Order By: Relevance
“…The former studies report that the five-year overall survival rate is 21 to 41% [1,2,4,5]. In this study, we found median survival to be 48.1 months and five-year overall survival rate to be 45.6% in 250 pneumonectomy cases.…”
Section: Discussionsupporting
confidence: 56%
See 3 more Smart Citations
“…The former studies report that the five-year overall survival rate is 21 to 41% [1,2,4,5]. In this study, we found median survival to be 48.1 months and five-year overall survival rate to be 45.6% in 250 pneumonectomy cases.…”
Section: Discussionsupporting
confidence: 56%
“…Nonetheless, the role of neoadjuvant therapy is still questionable. Some series report lower postoperative mortality following neoadjuvant therapy [2], while others report higher early postoperative mortality [14] or higher mortality only in right pneumonectomy [15]. Our study showed a statistically significant difference in early mortality following neoadjuvant therapy.…”
Section: Discussionsupporting
confidence: 42%
See 2 more Smart Citations